Revio | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

52 results for “Revio”

Trials

View all 29 →

Chidamide in Combination With Azacitidine, Liposomal Mitoxantrone, and Prednisone (CAMP Regimen) for the Treatment of Previously Untreated Nodal TFH Cell Lymphoma

37 participants · First posted Jul 25, 2023

Oocyte Retrieval and Virtual Reality (REVPO)

150 participants · First posted Jun 23, 2021

REVI Pilot Feasibility Trial in Long-Term Care

18 participants · First posted Aug 3, 2026

Drugs

REVO-UWD-00B

REVO-UWD-19

REVO-UWD-01

Organizations

REVO BIOLOGICS

United States

REVO BIOLOGICS, INC.

United States

REVBIO - SERVICOS EM SANIDADE E NUTRICAO VEGETAL LTDA

Brazil

News

View all 15 →

Nanoform and Revio Therapeutics Partner to Develop GLIORA, a Novel Hydrogel Nanoformulation for High-Grade Glioma Treatment

Peptris Technologies Licenses India's First AI-Discovered Drug Candidate for Duchenne Muscular Dystrophy

PacBio and Radboud UMC Unveil Groundbreaking Study Results Using HiFi Long-Read Sequencing

Page 1 of 6